AUG 06, 2016 11:56 AM PDT

First Medical Marijuana Conference at Harvard Medical School

WRITTEN BY: Julianne Chiaet

Harvard Medical School recently hosted the first annual cannabis conference, where they awarded Rafael Mechoulam a lifetime achievement award. Mechoulam is an Israeli chemist known as the father of medical marijuana research. He identified the structure of cannabidiol in 1963 and isolated the active compound in marijuana, tetrahydrocannabinol (THC), in 1964.

"I thought that as soon as we knew the chemistry, the pharmacology, and the toxicity - and if there are any positive effects - companies will go in and take compounds and go ahead with clinical trials, which is true for a huge huge number of drugs," Mechoulam said to PBS.

The drug was made illegal one year after the 1936 release of "Reefer Madness." In the United States, it remains a schedule one controlled substance, in the same category as heroin. This classification has led to tight restrictions for researchers who want to research the drug.

Parents of epileptic children have strongly championed marijuana research within the last couple years due to the significant improvement medical marijuana has had on alleviating their children's seizures. Researchers believe the pace of research will dramatically quicken when marijuana becomes legal.
About the Author
Bachelor's (BA/BS/Other)
Julianne (@JuliChiaet) covers health and medicine for LabRoots. Her work has been published in The Daily Beast, Scientific American, and MailOnline. While primarily a science journalist, she has also covered culture and Japanese organized crime. She is the New York Board Representative for the Asian American Journalists Association (AAJA). • To read more of her writing, or to send her a message, go to
You May Also Like
Loading Comments...